Evifacotrep

CAS No. 2413739-88-3

Evifacotrep( —— )

Catalog No. M28273 CAS No. 2413739-88-3

Evifacotrep, a short transient receptor potential channel 5 ( TRPC5 ) antagonist (WO2020061162, compound 100), can be used for the research of neurological diseases .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 155 In Stock
5MG 188 In Stock
10MG 302 In Stock
25MG 465 In Stock
50MG 677 In Stock
100MG 1004 In Stock
200MG 1516 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Evifacotrep
  • Note
    Research use only, not for human use.
  • Brief Description
    Evifacotrep, a short transient receptor potential channel 5 ( TRPC5 ) antagonist (WO2020061162, compound 100), can be used for the research of neurological diseases .
  • Description
    Evifacotrep, a short transient receptor potential channel 5 ( TRPC5 ) antagonist (WO2020061162, compound 100), can be used for the research of neurological diseases .(In Vitro):Evifacotrep is a short transient receptor potential channel 5 ( TRPC5 ) antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    Raf|KRAS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2413739-88-3
  • Formula Weight
    441.77
  • Molecular Formula
    C18H12ClF4N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (113.18 mM)
  • SMILES
    O=C1NN=CC(N2Cc3ncnc(Oc(cc4)c(C(F)(F)F)cc4F)c3CC2)=C1Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Huestis MP, et al. Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor. ACS Med Chem Lett. 2021 Apr 21;12(5):791-797.
molnova catalog
related products
  • SB 452533

    SB 452533 is an antagonist of the vanilloid receptor 1(pKb: 7.8).

  • PF-04745637

    PF-04745637 is a potent and selective TRPA1 antagonist with an IC50 of 17 nM.

  • Probenecid

    The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate.